Alternatively, miR-200c-3p modulates the expression of metabolic enzyme cytochrome P450 1B1 (CYP1B1) and transcription factor SOX2 in renal cell carcinoma and breast cancer, respectively. This evidence concerns the gene SOX2 and renal cell carcinoma.